Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_assertion description "[Therefore, these findings suggest that exogenous activation of the Mas receptor protects from ADR-induced nephropathy and contributes to the beneficial effects of AT1 receptor blockade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_assertion evidence source_evidence_literature NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_assertion SIO_000772 23762470 NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_assertion wasDerivedFrom befree-20150227 NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_assertion wasGeneratedBy ECO_0000203 NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP255184.RA2XwzefT0kFJG-Fia7x5o1FKSR_sCfd55XomwP7ADM-A130_provenance.